Home  |  Contact

UniProtKB/Swiss-Prot P06576: Variant p.Glu274Gln

ATP synthase subunit beta, mitochondrial
Gene: ATP5F1B
Variant information

Variant position:  274
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glutamate (E) to Glutamine (Q) at position 274 (E274Q, p.Glu274Gln).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and acidic (E) to medium size and polar (Q)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  274
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  529
The length of the canonical sequence.

Location on the sequence:   GVINLKDATSKVALVYGQMN  E PPGARARVALTGLTVAEYFR
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GVINLKDATSKVALVYGQMNEPPGARARVALTGLTVAEYFR

Mouse                         GVINLKDATSKVALVYGQMNEPPGARARVALTGLTVAEYFR

Rat                           GVINLKDATSKVALVYGQMNEPPGARARVALTGLTVAEYFR

Bovine                        GVINLKDATSKVALVYGQMNEPPGARARVALTGLTVAEYFR

Chicken                       GVINLKDATSKVALVYGQMNEPPGARARVALTGLTVAEYFR

Caenorhabditis elegans        GVIDLKGKNSKVSLVYGQMNEPPGARARVCLTGLTVAEYFR

Drosophila                    GVISLKDKTSKVALVYGQMNEPPGARARVALTGLTVAEYFR

Slime mold                    GVIKKEGPGSKVALVFGQMNEPPGARARVTLTGLTVAEYFR

Baker's yeast                 GVINLEGE-SKVALVFGQMNEPPGARARVALTGLTIAEYFR

Fission yeast                 GVIKLEGE-SKAALVFGQMNEPPGARARVALTGLTVAEYFR

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 48 – 529 ATP synthase subunit beta, mitochondrial
Modified residue 259 – 259 N6-acetyllysine; alternate
Modified residue 259 – 259 N6-succinyllysine; alternate
Modified residue 264 – 264 N6-acetyllysine; alternate
Modified residue 264 – 264 N6-succinyllysine; alternate


Literature citations

Gene structure of the human mitochondrial adenosine triphosphate synthase beta subunit.
Ohta S.; Tomura H.; Matsuda K.; Kagawa Y.;
J. Biol. Chem. 263:11257-11262(1988)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANT GLN-274;

Human F1-ATPase: molecular cloning of cDNA for the beta subunit.
Ohta S.; Kagawa Y.;
J. Biochem. 99:135-141(1986)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANT GLN-274;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.